Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome

References

• Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod 2004;19:1176–80
   PubMed Web of Science ®Google Scholar
• Tesarik J, Hazout A, Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod 2006;21:2572–9
   PubMed Web of Science ®Google Scholar
• Chen SL, Ye DS, Chen X, et al. Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol. Hum Reprod 2012;27:1351–6
   PubMed Web of Science ®Google Scholar
• Zelinski-Wooten MB, Hutchison JS, Hess DL, et al. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum Reprod 1995;10:1658–66
   PubMed Web of Science ®Google Scholar
• Humaidan P, Bredkjaer HE, Bungum L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2005;20:1213–20
   PubMed Web of Science ®Google Scholar
• Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod 2009;24:2389–94
   PubMed Web of Science ®Google Scholar
• Papanikolaou E, Verpoest W, Fatemi H, et al. A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil Steril 2011;95:1174–7
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Baruffi R, Petersen CG, et al. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol 2010;8:107–12
   PubMed Web of Science ®Google Scholar
• Humaidan P, Van Vaerenbergh I, Bourgain C, et al. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum Reprod 2012;27:3259–72
   PubMed Web of Science ®Google Scholar
• Endo T, Honnma H, Hayashi T, et al. Continuation of GnRH agonist administration for 1 week, after hCG injection, prevents ovarian hyperstimulation syndrome following elective cryopreservation of all pronucleate embryos. Hum Reprod 2002;17:2548–51
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Nygren KG, Adamson GD, et al. The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology. Fertil Steril 2006;86:16–19
   PubMed Web of Science ®Google Scholar
• Imbar T, Kol S, Lossos F, et al. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum Reprod 2012;27:753–9
   PubMed Web of Science ®Google Scholar
• Tonguc E, Var T, Ozyer S, et al. Estradiol supplementation during the luteal phase of in vitro fertilization cycles: a prospective randomized study. Eur J Obstet Gynecol Reprod Biol 2011;154:172–6
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Motta L, Lòpez A, et al. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach. Fertil Steril 2010;94:2820–3
   PubMed Web of Science ®Google Scholar
• Pirard C, Donnez J, Loumaye E. GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Hum Reprod 2006;21:1894–900
   PubMed Web of Science ®Google Scholar
• Qublan H, Amarin Z, Al-Qudah M, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of ≤7mm on day of egg retrievial. Hum Fertil 2008;11:43–7
   Google Scholar
• Razieh DF, Maryam AR, Nasim T. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection. Taiwan J Obstet Gynecol 2009;48:245–8
   PubMed Web of Science ®Google Scholar
• Pirard C, Donnez J, Loumaye E. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Hum Reprod 2005;20:1798–804
   PubMed Web of Science ®Google Scholar
• Iwashita M, Kudo Y, Shinozaki Y, Takeda Y. Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J 1993;40:539–44
   PubMed Web of Science ®Google Scholar
• Lin LS, Roberts VJ, Yen SS. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. J Clin Endocrinol Metab 1995;80:580–5
   PubMed Web of Science ®Google Scholar
• Herman A, Ron-El R, Golan A, et al. Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone. Hum Reprod 1992;7:465–8
   PubMed Web of Science ®Google Scholar
• Gartner B, Moreno C, Marinaro A, et al. Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle. Hum Reprod 1997;12:2557–9
   PubMed Web of Science ®Google Scholar
• Golan A. Fetal outcome following inadvertent administration of long-acting D-Trp6 LH-RH microcapsules during pregnancy: a case report. Hum Reprod 1990;5:123–4
   PubMed Web of Science ®Google Scholar
• Murdoch WJ. Immunolocalization of a GnRH receptor site in murine endometrium that mediates apoptosis. Cell Tissue Res 1995;282:527–9
   PubMed Web of Science ®Google Scholar
• Reshef E, Lei ZM, Rao CV, et al. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes and deciduas. J Clin Endocrinol Metab 1990;70:421–30
   PubMed Web of Science ®Google Scholar